
Mirin Market Size, Share, Trends, Industry Analysis Report: By Type (Aji-mirin and Hon-mirin), By Application (Residential and Commercial), By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Afric
Description
Mirin Market Size, Share, Trends, Industry Analysis Report: By Type (Aji-mirin and Hon-mirin), By Application (Residential and Commercial), By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024–2032
The global mirin market size is expected to reach USD 425.03 million by 2032, according to a new study by Polaris Market Research. The report “Global Mirin Market Size, Share, Trends, Industry Analysis Report: By Type (Aji-mirin and Hon-mirin), By Application (Residential and Commercial), By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024–2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global mirin market is experiencing notable growth owing to the increasing consumer interest in authentic Japanese cuisines and a rising preference for versatile cooking ingredients. Key drivers include the growing popularity of Asian culinary traditions, the expansion of Japanese restaurants and food products worldwide, and emerging home cooking and gourmet food trends. Additionally, the shift in preference of health-conscious consumers toward natural and less processed ingredients has propelled the demand for mirin, a naturally fermented rice wine.
Trends shaping the mirin market include innovations in mirin production, such as low-sugar and premium variants, and the expansion of distribution channels, including online grocery platforms and specialty stores.
The competitive landscape of the global mirin market is characterized by a mix of traditional producers and emerging players focusing on premium and specialty products. Established companies such as Kikkoman and Mizkan leverage their extensive distribution networks and brand reputation to maintain market dominance.
Mirin Market Report Highlights:
- Aji-mirin, often referred to as ""fake"" or ""sweetened"" mirin, is the dominating segment due to its widespread availability, affordability, and suitability for a variety of culinary applications.
- By application, the commercial segment dominates the global mirin market.
- Based on distribution channel, the supermarkets & hypermarkets segment dominates the global mirin market. These retail formats offer a broad selection of food products, including mirin, making them a primary shopping destination for consumers seeking convenience and variety.
- Asia Pacific dominates the global market, primarily due to its cultural affinity for Japanese cuisine and the high consumption rates of mirin in countries such as Japan, China, and South Korea.
- The major players in the market include Kikkoman Corporation, Mizkan Holdings, Yamasa Corporation, Takara Shuzo Co., Ltd., Ohsawa Japan, Marukin Shoyu Co., Ltd., Suzuya Co., Ltd., Shoda Shoyu Co., Ltd., Maruzen Showa Co., Ltd., Shinkichi Kogyo Co., Ltd., Lee Kum Kee, Aji-No-Moto Co., Ltd., Nakano Vinegar Co., Ltd., Sun Noodles, Inc., San-J International, Inc.
Mirin– Type-Based Outlook (Revenue – USD Billion, 2019–2032)
- Aji-mirin
- Hon-mirin
- Residential
- Commercial
- Supermarkets & Hypermarkets
- Convenience Stores
- Online
- North America
Canada
- Europe
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
- Asia Pacific
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
- Middle East & Africa
UAE
Israel
South Africa
Rest of Middle East & Africa
- Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
117 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Hormonal Contraceptive Market Insights
- 4.1. Hormonal Contraceptive Market – Market Snapshot
- 4.2. Hormonal Contraceptive Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Demand for Long-Acting Reversible Contraceptives (LARCs) Is Driving the Market Growth
- 4.2.1.2. Shift Towards Personalized and Convenient Contraceptive Options Propels the Market
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Health Concerns and Side Effects is hindering the Hormonal Contraceptive Market Growth
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hormonal Contraceptive Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Hormonal Contraceptive Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 5.3. Pills
- 5.3.1. Global Hormonal Contraceptive Market, by Pills, by Region, 2019-2032 (USD Billion)
- 5.4. Skin Patches
- 5.4.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
- 5.5. Hormonal Implants
- 5.5.1. Global Hormonal Contraceptive Market, by Hormonal Implants, by Region, 2019-2032 (USD Billion)
- 5.6. Vaginal Rings
- 5.6.1. Global Hormonal Contraceptive Market, by Vaginal Rings, by Region, 2019-2032 (USD Billion)
- 5.7. Skin Patches
- 5.7.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
- 5.8. Others
- 5.8.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)
- 6. Global Hormonal Contraceptive Market, by Hormone
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 6.3. Progestin Only
- 6.3.1. Global Hormonal Contraceptive Market, by Progestin Only, by Region, 2019-2032 (USD Billion)
- 6.4. Combined Hormone Contraceptives
- 6.4.1. Global Hormonal Contraceptive Market, by Combined Hormone Contraceptives, by Region, 2019-2032 (USD Billion)
- 7. Global Hormonal Contraceptive Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Hospital Pharmacies
- 7.3.1. Global Hormonal Contraceptive Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
- 7.4. Retail Pharmacies
- 7.4.1. Global Hormonal Contraceptive Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
- 7.5. Others
- 7.5.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)
- 8. Global Hormonal Contraceptive Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Hormonal Contraceptive Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Hormonal Contraceptive Market – North America
- 8.3.1. North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.3. North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4. Hormonal Contraceptive Market – U.S.
- 8.3.4.1. U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5. Hormonal Contraceptive Market – Canada
- 8.3.5.1. Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4. Hormonal Contraceptive Market – Europe
- 8.4.1. Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.3. Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4. Hormonal Contraceptive Market – UK
- 8.4.4.1. UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5. Hormonal Contraceptive Market – France
- 8.4.5.1. France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.5.3. France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6. Hormonal Contraceptive Market – Germany
- 8.4.6.1. Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7. Hormonal Contraceptive Market – Italy
- 8.4.7.1. Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8. Hormonal Contraceptive Market – Spain
- 8.4.8.1. Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9. Hormonal Contraceptive Market – Netherlands
- 8.4.9.1. Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10. Hormonal Contraceptive Market – Russia
- 8.4.10.1. Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.11. Hormonal Contraceptive Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.11.2. Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.11.3. Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5. Hormonal Contraceptive Market – Asia Pacific
- 8.5.1. Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4. Hormonal Contraceptive Market – China
- 8.5.4.1. China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.4.3. China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5. Hormonal Contraceptive Market – India
- 8.5.5.1. India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.5.3. India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6. Hormonal Contraceptive Market – Malaysia
- 8.5.6.1. Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7. Hormonal Contraceptive Market – Japan
- 8.5.7.1. Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8. Hormonal Contraceptive Market – Indonesia
- 8.5.8.1. Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9. Hormonal Contraceptive Market – South Korea
- 8.5.9.1. South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.10. Hormonal Contraceptive Market – Australia
- 8.5.10.1. Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.10.2. Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.10.3. Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.11. Hormonal Contraceptive Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6. Hormonal Contraceptive Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4. Hormonal Contraceptive Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5. Hormonal Contraceptive Market – UAE
- 8.6.5.1. UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6. Hormonal Contraceptive Market – Israel
- 8.6.6.1. Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7. Hormonal Contraceptive Market – South Africa
- 8.6.7.1. South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.8. Hormonal Contraceptive Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7. Hormonal Contraceptive Market – Latin America
- 8.7.1. Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4. Hormonal Contraceptive Market – Mexico
- 8.7.4.1. Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5. Hormonal Contraceptive Market – Brazil
- 8.7.5.1. Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6. Hormonal Contraceptive Market – Argentina
- 8.7.6.1. Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.7. Hormonal Contraceptive Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.7.2. Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.7.3. Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Bayer AG
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Pfizer Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Merck & Co., Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Johnson & Johnson
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. AbbVie Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. GlaxoSmithKline plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Mylan N.V.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Teva Pharmaceutical Industries Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Novartis AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. HRA Pharma
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Mithra Pharmaceuticals
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Celgene Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Allergan plc
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Procter & Gamble Co.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Reddy's Laboratories Ltd.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.